None listed
Conditions
Brief summary
In this trial, patients undergoing elective colonoscopy under sedation will be randomised to BIS-guided sedation targeting either “light” or “deep” sedation. Sedation will be achieved with a standardised regimen of target-controlled infusion of propofol and fentanyl bolus. The primary end point will be the incidence of procedure recall in each group. The procedural conditions, cardio-respiratory complications and recovery including cognitive function will be assessed. The patient satisfaction with anaesthesia care will be recorded.
Interventions
Sedation will be with an intravenous infusion of propofol (a IV anaesthetic agent) using TCI effect site steered dosing with a start point of 1.5mcg/ml. This will be titrated by the anaesthetist to achieve the target BIS with no maximum dose. A bolus dose of fentanyl (an opioid) of 0.7mcg/kg to a maximum of 100mcg will be given for those under 70 years, and for those over 70 years this will be 0.5mcg/kg to a maximum of 75mcg. The sedation will continue for the duration of the colonoscopy (usual duration 20-30 mins). The bispectral index (BIS) is a modified EEG signal which is a validated measure for the depth of anaesthesia which generates a number from 0 (no cortical activity) to 100 (awake). Measurement is made by the placement of a measurement strip on the patient's forehead. In this study the intervention is "light sedation" in which the BIS target will be 70-80. The propofol infusion will be increased or decreased to remain in this range.
Sponsors
Study design
Eligibility
Inclusion criteria
Booked for elective outpatient colonoscopy under sedation ASA physical status grade 1-3 Adequate english language comprehension to complete study procedures Cognitive function sufficient to provide own consent for the procedure
Exclusion criteria
Booked for combined colonoscopy and gastroscopy emergency inpatient procedures significant cardio-respiratory dysfunction (ASA4-5)